| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") | 8,963,171 | 6,839,857 | 6,778,214 | 5,576,393 | 5,829,026 | 33,986,661 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 2,768,420 | 3,613,926 | 4,139,547 | 4,812,248 | 3,689,699 | 19,023,840 |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | 0 | 0 | 0 | 0 | 0 | |
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | -4,875 | -14,871 | -1,895 | -8,044 | -7,006 | -36,691 |
| 6 | Total. Add lines 1 through 5 | 11,726,716 | 10,438,912 | 10,915,866 | 10,380,597 | 9,511,719 | 52,973,810 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | 0 | |||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | 0 | |||||
| c | Add lines 7a and 7b.. | 0 | |||||
| 8 | Public support. (Subtract line 7c from line 6.) | 52,973,810 | |||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6 | 11,726,716 | 10,438,912 | 10,915,866 | 10,380,597 | 9,511,719 | 52,973,810 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources | 1,227 | 5,924 | 32,253 | 7,994 | 226 | 47,624 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975 | ||||||
| c | Add lines 10a and 10b | 1,227 | 5,924 | 32,253 | 7,994 | 226 | 47,624 |
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | 0 | 0 | 0 | 0 | 0 | |
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 11,727,943 | 10,444,836 | 10,948,119 | 10,388,591 | 9,511,945 | 53,021,434 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6Total annual distributions. Add lines 1 through 5. | 6 | |
|
7
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
7 | |
| 8 Distributable amount for 2025 from Section C, line 6 | 8 | |
| 9 Line 7 amount divided by Line 8 amount | 9 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2025 |
(iii) Distributable Amount for 2025 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2025 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2025 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2025: | ||||
| a From 2020....... | ||||
| b From 2021....... | ||||
| c From 2022....... | ||||
| d From 2023....... | ||||
| e From 2024....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2025 distributable amount | ||||
|
i
Carryover from 2020 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2025 from Section D, line 6: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2025 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2025, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2025. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2026. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2021..... | ||||
| b Excess from 2022..... | ||||
| c Excess from 2023..... | ||||
| d Excess from 2024..... | ||||
| e Excess from 2025..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
| Return Reference | Explanation |
|---|---|
| FORM 990, PART I, LINE 1 | THE PURPOSE OF TISCH MULTIPLE SCLEROSIS RESEARCH CENTER OF NY, INC. IS TO CONDUCT MEDICAL RESEARCH DIRECTED TOWARD FINDING THE CAUSE AND EVENTUAL CURE FOR MULTIPLE SCLEROSIS. |
| FORM 990, PART III, LINE 4A | TISCH MS RESEARCH CENTER OF NEW YORK'S (TISCH MSRCNY) MISSION IS TO CONDUCT MEDICAL RESEARCH DIRECTED TOWARD DISCOVERING THE CAUSE OF AND EVENTUAL CURE FOR MULTIPLE SCLEROSIS. THESE RESEARCH INITIATIVES INCLUDE: TO BETTER UNDERSTAND AND TREAT COORDINATION AND BALANCE DIFFICULTIES IN PATIENTS WITH MS. TO CREATE AN EXPERIMENTAL MODEL OF PROGRESSIVE MS THAT WILL ENABLE US TO BETTER UNDERSTAND AND TREAT PATIENTS WITH SECONDARY PROGRESSIVE MS (SPMS) AND PRIMARY PROGRESSIVE MS (PPMS). TO UTILIZE NOVEL CEREBROSPINAL FLUID BASED ANIMAL MODELS TO BETTER UNDERSTAND OTHER NEURODEGENERATIVE DISEASES SUCH AS MS AND ALS. TO DEVELOP ORGANOID MODELS TO BETTER UNDERSTAND THE UNDERPINNINGS OF PROGRESSIVE MS. FINALLY, AND PERHAPS MOST IMPORTANTLY, TO IDENTIFY THE INITIAL TRIGGER(S) THAT CAUSE MS. IN 2025, DRS WONG AND SADIQ PUBLISHED RESULTS FROM A COLLABORATION WITH NEURON23, INC. IN THE PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES. THE STUDY USED THE PPMS ANIMAL MODEL DEVELOPED AT TISCH MS TO DEMONSTRATE PROOF OF CONCEPT OF A NOVEL MS THERAPEUTIC. IN 2025, TISCH MSRCNY RESEARCHERS WERE INVITED TO PRESENT RESEARCH ABSTRACTS AT THE ANNUAL CONFERENCES OF ACTRIMS (AMERICAS COMMITTEE FOR TREATMENT AND RESEARCH IN MS), THE AMERICAN ADADEMY OF NEUROLOGY AND THE SOCIETY FOR NEUROSCIENCE. |
| FORM 990, PART III, LINE 4B | AS AN ACADEMIC FACILITY, THE TISCH MS RESEARCH CENTER PROVIDES EDUCATIONAL AND TRAINING RESOURCES FOR MS RESEARCHERS AND MEDICAL PROFESSIONALS. ONE OF THE MOST IMPORTANT GOALS OF TISCH MSRCNY IS TO PROVIDE RESEARCH OPPORTUNITIES FOR YOUNG SCIENCE GRADUATES THAT ENABLE THEM TO BECOME CAREER SCIENTISTS. SINCE ITS INCEPTION, THEY HAVE TRAINED OVER 100 COLLEGE GRADUATES AS RESEARCH ASSISTANTS (RAS) FOR 2-YEAR ROTATIONS. IN 2025, ALL SECOND YEAR RESEARCH ASSISTANTS, UNDER THE GUIDANCE OF TISCH MSRCNY PRINCIPAL INVESTIGATORS, MATRICULATED TO TOP MEDICAL SCHOOLS AND GRADUATE PROGRAMS. FELLOWSHIPS IN MS RESEARCH ARE ALSO OFFERED TO PHYSICIANS AND SCIENTISTS INTERESTED IN ENTERING OR EXPANDING THEIR WORK IN THIS FIELD. WEEKLY JOURNAL CLUB MEETINGS OR GRAND ROUNDS TAKE PLACE IN OUR CONFERENCE ROOM TO DISCUSS THE LATEST ADVANCEMENTS IN MS RESEARCH AND HOW IT APPLIES TO OUR CURRENT INVESTIGATIONS. |
| FORM 990, PART VI, SECTION A, LINE 2 | THE FOLLOWING DIRECTORS ARE RELATED AS HUSBAND AND WIFE: THOMAS AND MUSA MAYER CLIFFORD AND BONNIE EISLER RICHARD AND GRETA RUBIN SCHWARTZ JAMES AND BERNADETTE MARIANI DEVEN AND MONIKA PAREKH PHIL AND ALLA WEISBERG DANIEL AND BONNIE TISCH |
| FORM 990, PART VI, SECTION A, LINE 4 | CHANGES TO BYLAWS: ARTICLE II, SECTION 2(B) "ENTIRE BOARD" DEFINITION EXPANDED TO EXPLICITLY BE DEFINED AS "THE TOTAL NUMBER OF DIRECTORS ENTITLED TO VOTE WHICH THE CORPORATION WOULD HAVE IF THERE WERE NO VACANCIES, AND INCLUDES "THE TERMS OF ANY DIRECTORS WHOSE TERMS HAVE NOT YET EXPIRED." ARTICLE II, SECTION 3 MEETING SUCCESSION HAS BEEN CLARIFIED. IF BOTH THE CHAIR AND VICE CHAIR(S) ARE ABSENT, A DIRECTOR DESIGNATED BY THE CHAIR WHO IS ON THE EXECUTIVE COMMITTEE PRESIDES (BEFORE DEFAULTING TO A DIRECTOR CHOSEN BY MAJORITY). THE PREVIOUS BYLAWS WENT FROM VICE CHAIR TO MAJORITY-CHOSEN DIRECTOR. ARTICLE II, SECTION 4 REMOVAL OF A DIRECTOR NOW REQUIRES CAUSE. THIS HAS BEEN CHANGED FROM "WITH OR WITHOUT CAUSE" TO "WITH CAUSE" BY MAJORITY OF THE ENTIRE BOARD. ARTICLE II, SECTION 6 VIRTUAL MEETINGS EXPLICITLY AUTHORIZED WITH NEW LANGUAGE: MEETINGS MAY BE HELD "INCLUDING VIRTUALLY." ARTICLE II, SECTION 6 NOTICE METHODS NARROWED. THE PREVIOUS BYLAWS ALLOWED NOTICE ORALLY (1 DAY), OR BY FAX/EMAIL/MAIL (3 DAYS). THE NEW BYLAWS ALLOW ONLY EMAIL, MAIL, OR COURIER, ALL WITH A UNIFORM 3-DAY NOTICE. ORAL, TELEPHONE, AND FAX NOTICE ARE ELIMINATED. ARTICLE II, SECTION 6 "WITHOUT NOTICE" LANGUAGE FOR REGULAR MEETINGS HAS BEEN REMOVED. ARTICLE II, SECTION 8 ADJOURNMENT NOW REQUIRES NOTICE. PREVIOUSLY, AN ADJOURNED MEETING COULD BE MOVED "WITHOUT NOTICE TO ANY DIRECTOR." THE NEW BYLAWS REQUIRE NOTICE FROM DIRECTORS NOT PRESENT AT THE ADJOURNMENT UNLESS ANNOUNCED AT THE MEETING. ARTICLE II, SECTION 9(A) RECUSED DIRECTORS COUNT TOWARD QUORUM. NEW PROVISION: DIRECTORS PRESENT BUT NOT VOTING DUE TO A CONFLICT OF INTEREST OR RELATED-PARTY TRANSACTION ARE STILL "PRESENT" FOR QUORUM PURPOSES AT THE TIME OF THE VOTE. ARTICLE II, SECTION 9(B) THE PREVIOUS BYLAWS ALLOWED REAL PROPERTY TRANSACTIONS NOT REQUIRING BOARD APPROVAL TO BE APPROVED BY A COMMITTEE. NEW LANGUAGE ON THE CHANGED BYLAWS NOW REQUIRES A MAJORITY VOTE OF THE BOARD OR A COMMITTEE FOR ANY SUCH "OTHER" REAL PROPERTY TRANSACTION. ARTICLE II, SECTION 10 ANNUAL REPORT PRESENTER CHANGED. THE PREVIOUS BYLAWS HAD THE BOARD PRESENT THE REPORT, CERTIFIED BY INDEPENDENT ACCOUNTANTS. THE NEW BYLAWS HAVE THE PRESIDENT AND TREASURER PRESENT THE ANNUAL REPORT AND ALLOW VERIFICATION BY THE P&T OR A MAJORITY OF DIRECTORS AS AN ALTERNATIVE TO CERTIFICATION BY INDEPENDENT ACCOUNTANTS. ARTICLE II, SECTION 11(B) TREASURER MAY DELEGATE. ADDED OR THEIR DESIGNATE" TO THE TREASURER'S ANNUAL DONOR-RESTRICTED ASSET REPORTING DUTY. ARTICLE III, SECTION 1 HEIGHTENED THRESHOLD FOR EXECUTIVE COMMITTEE APPOINTMENTS ON LARGE BOARDS. WHEN THE BOARD HAS 30 OR MORE MEMBERS, EXECUTIVE COMMITTEE APPOINTMENTS NOW REQUIRE THREE-QUARTERS OF THE DIRECTORS TO BE PRESENT RATHER THAN A SIMPLE MAJORITY OF THE ENTIRE BOARD. ARTICLE III, SECTION 1 SIGNIFICANTLY EXPANDED LIST OF ACTIONS COMMITTEES CANNOT TAKE. NEW RESTRICTIONS ADDED BEYOND THE ORIGINAL FOUR: (E) ELECTING OR REMOVING OFFICERS AND DIRECTORS, (F) APPROVING MERGERS OR PLANS OF DISSOLUTION, (G) AUTHORIZING SALE/LEASE/DISPOSITION OF ALL OR SUBSTANTIALLY ALL ASSETS, AND (H) APPROVING AMENDMENTS TO THE CERTIFICATE OF INCORPORATION. ARTICLE III, SECTION 2 NON-DIRECTORS MAY SERVE ON COMMITTEES OF THE CORPORATION. NEW LANGUAGE EXPLICITLY PERMITS NON-DIRECTORS TO SERVE ON THESE (NON-BOARD) COMMITTEES. ARTICLE III, SECTION 4 NOMINATING COMMITTEE ROLE CLARIFIED. THE COMMITTEE NOW PRESENTS NOMINEES "FOR THEM [THE BOARD] TO VOTE UPON" RATHER THAN "FOR NOMINATION." ARTICLE IV, SECTION 8 BACKUP PRESIDER WHEN NO VICE CHAIR. IF THERE IS NO VICE CHAIR, A MEMBER OF THE EXECUTIVE COMMITTEE SELECTED BY THE BOARD PRESIDES. ARTICLE IV, SECTION 9 TREASURER'S ROLE REMOVED THE BOND REQUIREMENT ("IF REQUIRED BY THE BOARD OBTAIN A BOND"). ADDED NEW OVERSIGHT RESPONSIBILITIES SUCH AS, ASSISTING THE BOARD WITH FINANCIAL OVERSIGHT AND LEGAL/REGULATORY COMPLIANCE, WORKING "IN CONJUNCTION WITH THE AUDIT COMMITTEE," ENSURING SOUND FINANCIAL PRACTICES AND TIMELY REPORTING, AND A "KEY ROLE" IN BUDGETING, FINANCIAL PLANNING, AND MONITORING FISCAL POLICIES. EXPLICITLY ALLOWS THE TREASURER TO DELEGATE BOOKKEEPING/CUSTODY DUTIES TO STAFF. ARTICLE IV, SECTION 10 NEW PARAGRAPH PERMITS THE SECRETARY TO DELEGATE DUTIES TO STAFF WHILE RETAINING OVERALL RESPONSIBILITY. ARTICLE VII, SECTION 3 ADVANCEMENT OF EXPENSES HAVE BEEN MODIFIED TO INCLUDE TWO NEW CONDITIONS: (1) THE BOARD MUST DETERMINE THE PERSON WAS ACTING IN GOOD FAITH BEFORE ADVANCING EXPENSES, AND (2) THE REPAYMENT OBLIGATION NOW ALSO COVERS SITUATIONS "WHERE INDEMNIFICATION IS GRANTED, TO THE EXTENT THE EXPENSES SO ADVANCED EXCEED THE INDEMNIFICATION TO WHICH HE/SHE IS ENTITLED." ARTICLE VIII, SECTION 2 WHISTLEBLOWER POLICY IS NOW REQUIRED. THE LIST OF POLICIES THE BOARD MUST ADOPT NOW EXPLICITLY INCLUDES A WHISTLEBLOWER POLICY IN ADDITION TO A CONFLICTS OF INTEREST POLICY WHILE ALSO ADDING "AS ARE REQUIRED BY LAW" TO THE POLICIES THE BOARD MUST ADOPT. ARTICLE VIII, SECTION 3 BOOKS AND RECORDS SCOPE HAVE BEEN BROADENED TO NOW REQUIRE MINUTES TO COVER "ANY COMMITTEES OF THE BOARD" RATHER THAN ONLY "ANY STANDING COMMITTEES OF THE BOARD." |
| FORM 990, PART VI, SECTION B, LINE 11B | WHEN FORM 990 IS PRESENTED TO THE ORGANIZATION, THE AUDIT COMMITTEE WILL REVIEW AND SEND IT TO THE BOARD FOR COMMENT. IF NONE IS RECEIVED IN 7 DAYS, THE RETURN IS FILED. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE BOARD MEMBERS COMPLETE AN "ANNUAL CONFLICT OF INTEREST DISCLOSURE STATEMENT." |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPENSATION IS DETERMINED USING PUBLICLY AVAILABLE COMPENSATION INFORMATION FROM COMPARABLE RESEARCH ORGANIZATIONS AND UNIVERSITIES, WHICH IS REVIEWED AND APPROVED BY DR. SADIQ. COMPENSATION IS DETERMINED USING PUBLICLY AVAILABLE COMPENSATION INFORMATION FROM COMPARABLE RESEARCH ORGANIZATIONS AND UNIVERSITIES, WHICH IS REVIEWED AND APPROVED BY DR. SADIQ. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S WEBSITE WILL DISPLAY THE FINANCIALS AND FORM 990 FOR PUBLIC VIEWING. IN ADDITION, BOTH THE FINANCIALS AND FORM 990 ARE AVAILABLE UPON REQUEST. |
| FORM 990, PART XII, LINE 2C: | THE PROCESS OF OVERSEEING THE AUDIT AND SELECTION OF INDEPENDENT ACCOUNTANT'S HAS NOT BEEN CHANGED FROM PRIOR YEAR. |
| PT XI: GIFTS IN KIND - GOODS AND MATERIALS | OTHER: REQUIRED DISCLOSURE OF NON-CASH SECURITIES FROM ANONYMOUS DONORS TOTALING $9,903. |
| Software ID: | |
| Software Version: |